US government helps develop Ebola drug; State medical schools beat the Ivy League in list of Top 25

News From Around the Web

> The U.S. government plans to help North Carolina-based BioCryst Pharmaceuticals develop a new Ebola drug, one of five currently being tested against the virus. BCX4430, BioCryst's drug, is a small molecule that prevents the virus from reproducing in the body, according to NBC News. Article

> The University of Washington was ranked the top medical school by a panel of doctors from diverse backgrounds and specialties, followed by other big publicly-funded state schools that beat out out the Ivy League, Business Insider reported. Article

H&HN Daily examines why hospitals and health systems must consider vertical integration partnerships, which bring together the supply and demand side of the medical marketplace. Article

Health IT News

> Healthcare organizations must address consumers' concerns about individual control and privacy of their information to make health information exchanges and distributed research networks work. Article

> Data from Internet searches could help predict trends in non-communicable diseases including heart disease and diabetes. Article

And Finally… Million dollar winners--again. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.